<!DOCTYPE html>
<html lang="en"><head> <meta charset="utf-8"/> <meta content="width=device-width, initial-scale=1.0" name="viewport"/> <title>PM-JAY's Impact on Cancer</title> <style> body { font-family: Arial, sans-serif; margin: 20px; line-height: 1.6; color: #333; background-color: #f9f9f9; } h1 { background-color: #0066cc; color: white; padding: 15px; border-radius: 8px; } img { width: 100%; max-height: 300px; object-fit: cover; border-radius: 8px; margin: 20px 0; } h2 { color: #004d99; border-bottom: 2px solid #004d99; padding-bottom: 5px; }        .highlight { background-color: #fff9c4; padding: 5px; border-radius: 4px; }        .section { background-color: #ffffff; padding: 15px; margin: 15px 0; border-radius: 8px; box-shadow: 0 2px 5px rgba(0,0,0,0.1); } </style></head><body> <h1>PM-JAY's Impact on Cancer Treatment</h1> <img alt="Cancer Treatment" src="https://max-website20-images.s3.ap-south-1.amazonaws.com/Cancer_Treatment_e6eda2ea60.jpg"/> <div class="section"> <h2>Key Findings</h2> <p><span class="highlight">36% improvement</span> in timely cancer treatment overall.</p> <p><span class="highlight">90% improvement</span> for AB PM-JAY beneficiaries since 2018.</p> <p>Delays reduced in reproductive, genitourinary, breast, and blood cancers.</p> </div> <div class="section"> <h2>Demographic Insights</h2> <p>Better access for younger patients (&lt; 30 years: <span class="highlight">77%</span>).</p> <p>Higher education levels (70.2%) linked to faster treatment.</p> <p>Insurance coverage (69%) improved access; higher-income groups faced fewer delays.</p> </div> <div class="section"> <h2>Challenges</h2> <p>Delays in radiotherapy, chemotherapy, and surgery reduce survival rates.</p> <p>India has only <span class="highlight">779 radiotherapy machines</span>, far below WHO recommendations.</p> <p>High out-of-pocket expenses due to exclusions in AB PM-JAY.</p> <p>Public health spending remains below <span class="highlight">2% of GDP</span>.</p> </div> <div class="section"> <h2>Cancer in India</h2> <p>Cancer is characterized by uncontrolled cell proliferation harming healthy tissues.</p> <p>Cancer cases projected to rise from <span class="highlight">14.6 lakh in 2022</span> to <span class="highlight">15.7 lakh in 2025</span>.</p> <p><span class="highlight">Breast cancer</span> is the most prevalent, making up 13.6% of cases.</p> <p>Globally, <span class="highlight">20 million</span> new cases and <span class="highlight">9.7 million</span> deaths in 2022.</p> </div></body></html>